Recent news
June 2011
Funding increase for malaria research leads to largest pipeline of new tools
June 29, 2011 -- A new analysis of progress in the global fight against malaria has found a four-fold increase in annual funding for malaria research and development (R&D) in just 16 years—from $121 million in 1993 to $612 million in 2009, with a particularly rapid increase since 2004. The funding has generated the largest-ever pipeline of malaria control and prevention products, including new drugs, vaccines, insecticides, and diagnostics. The report, “Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty,” was authored by Policy Cures with input and funding from several product development partnerships working on new malaria interventions. It was published by PATH and the Roll Back Malaria Partnership.
The report also warns that even a small decline in annual funding could jeopardize this pipeline and derail the development of needed products. The report’s authors assessed progress to date against the R&D funding goals in the 2008 Global Malaria Action Plan and what will be needed in the coming decade to deliver the suite of products needed to manage, eliminate, and ultimately eradicate malaria from the
world. It calls for sustained, relatively modest increases that will boost total annual funding to $690 million by 2015, followed by a larger jump in 2016 to $785 million. See the links below for more details.
